Your browser doesn't support javascript.
Model-Based Analysis of SARS-CoV-2 Infections, Hospitalization and Outcome in Germany, the Federal States and Districts.
Dings, Christiane; Götz, Katharina Martha; Och, Katharina; Sihinevich, Iryna; Werthner, Quirin; Smola, Sigrun; Bliem, Marc; Mahfoud, Felix; Volk, Thomas; Kreuer, Sascha; Rissland, Jürgen; Selzer, Dominik; Lehr, Thorsten.
  • Dings C; Department of Clinical Pharmacy, Saarland University, 66123 Saarbrücken, Germany.
  • Götz KM; Department of Clinical Pharmacy, Saarland University, 66123 Saarbrücken, Germany.
  • Och K; Department of Clinical Pharmacy, Saarland University, 66123 Saarbrücken, Germany.
  • Sihinevich I; Department of Clinical Pharmacy, Saarland University, 66123 Saarbrücken, Germany.
  • Werthner Q; Department of Clinical Pharmacy, Saarland University, 66123 Saarbrücken, Germany.
  • Smola S; Institute of Virology, Saarland University Medical Center, 66421 Homburg, Germany.
  • Bliem M; Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research (HZI), 66123 Saarbrücken, Germany.
  • Mahfoud F; CompuGroup Medical (CGM), 56070 Koblenz, Germany.
  • Volk T; Department of Internal Medicine III (Cardiology, Angiology, Intensive Care Medicine), Saarland University Medical Center and Saarland University Faculty of Medicine, 66421 Homburg, Germany.
  • Kreuer S; Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
  • Rissland J; Department of Anesthesiology, University Hospital of the Saarland, 66421 Homburg, Germany.
  • Selzer D; Department of Anesthesiology, University Hospital of the Saarland, 66421 Homburg, Germany.
  • Lehr T; Institute of Virology, Saarland University Medical Center, 66421 Homburg, Germany.
Viruses ; 14(10)2022 09 24.
Article in English | MEDLINE | ID: covidwho-2043987
ABSTRACT
The coronavirus disease 2019 (COVID-19) pandemic challenged many national health care systems, with hospitals reaching capacity limits of intensive care units (ICU). Thus, the estimation of acute local burden of ICUs is critical for appropriate management of health care resources. In this work, we applied non-linear mixed effects modeling to develop an epidemiological SARS-CoV-2 infection model for Germany, with its 16 federal states and 400 districts, that describes infections as well as COVID-19 inpatients, ICU patients with and without mechanical ventilation, recoveries, and fatalities during the first two waves of the pandemic until April 2021. Based on model analyses, covariates influencing the relation between infections and outcomes were explored. Non-pharmaceutical interventions imposed by governments were found to have a major impact on the spreading of SARS-CoV-2. Patient age and sex, the spread of variant B.1.1.7, and the testing strategy (number of tests performed weekly, rate of positive tests) affected the severity and outcome of recorded cases and could reduce the observed unexplained variability between the states. Modeling could reasonably link the discrepancies between fine-grained model simulations of the 400 German districts and the reported number of available ICU beds to coarse-grained COVID-19 patient distribution patterns within German regions.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Observational study / Prognostic study Topics: Variants Limits: Female / Humans / Male Country/Region as subject: Europa Language: English Year: 2022 Document Type: Article Affiliation country: V14102114

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Observational study / Prognostic study Topics: Variants Limits: Female / Humans / Male Country/Region as subject: Europa Language: English Year: 2022 Document Type: Article Affiliation country: V14102114